The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Host-microbial interactions in the metabolism of therapeutic and diet-derived xenobiotics
Open accessAbstract
Our associated microbial communities play a critical role in human health and predisposition to disease, but the degree to which they also shape therapeutic interventions is not well understood. Here, we integrate results from classic and current studies of the direct and indirect impacts of the gut microbiome on the metabolism of therapeutic drugs and diet-derived bioactive compounds. We pay particular attention to microbial influences on host responses to xenobiotics, adding to the growing consensus that treatment outcomes reflect our intimate partnership with the microbial world, and providing an initial framework from which to consider a more comprehensive view of pharmacology and nutrition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“β-glucuronidases are another generalist enzyme family expressed by human-associated gut bacteria that influences the biological activity and toxicity of a wide range of drugs, dietary components, and endogenous metabolites47.”
From The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism (2016) · cites this paper as [47]
Experimental — accuracy not yet measuredIn the citing paper
“Many of these “diet-derived bioactive compounds” are metabolized by the gut microbiota (Fig. 4, Supplementary information S2 (table) and Supplementary information S3 (table)) and some are dependent on this transformation for activation and/or absorption47.”
From The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism (2016) · cites this paper as [47]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624
Projections of Global Mortality and Burden of Disease from 2002 to 2030
Mathers, C. D., & Loncar, D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030442 · Cited by 11,386
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100
Self-citationGut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597
Host-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277
Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
Koeth, R. A., Wang, Z., Levison, B. S., Buffa, J. A., Org, E., Sheehy, B. T., Britt, E. B., Fu, X., Wu, Y., Li, L., et al. (2013) · Nature Medicine · doi:10.1038/nm.3145 · Cited by 4,386
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk
Tang, W. H. W., Wang, Z., Levison, B. S., Koeth, R. A., Britt, E. B., Fu, X., Wu, Y., & Hazen, S. L. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1109400 · Cited by 3,400
Casarett and Doull's Toxicology: The Basic Science of Poisons
(1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-5-448_2 · Cited by 3,304
Dethlefsen, L., & Relman, D. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000087107 · Cited by 2,421
Dethlefsen, L., Huse, S., Sogin, M. L., & Relman, D. A. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060280 · Cited by 2,361
Research works printed but not linked: 6
- Finkel R, Cubeddu LX, Clark MA. Pharmacology. 4th ed. Baltimore, Maryland, USA: Lippincott Williams & Wilkins; 2009.
- Morotomi, 1986, J Natl Cancer Inst., 77, 195
- Gupta, 1994, Cancer Res., 54, 3723
- Kehrer, 2001, Clin Cancer Res., 7, 1136
- Zheng, 2013, Sci Transl Med., 5, 172ra122
- Okuda, 1997, Drug Metab Dispos., 25, 270
Cited by
Sorted by citations
Items 101–200 of 268
Dave, L. A., Hodgkinson, S. M., Roy, N. C., Smith, N. W., & McNabb, W. C. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.2012753 · Cited by 47
“2019; Carmody and Turnbaugh 2014; Spanogiannopoulos et al.”
BackgroundElsalem, L., Jum’ah, A. A., Alfaqih, M. A., & Aloudat, O. (2020) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s243337 · Cited by 38
Gut-Liver Immune Traffic: Deciphering Immune-Pathogenesis to Underpin Translational Therapy
Bozward, A. G., Ronca, V., Osei‐Bordom, D., & Oo, Y. H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.711217 · Cited by 36
Arabi, S. M., Bahrami, L. S., Rahnama, I., & Sahebkar, A. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106061 · Cited by 42
Brandt, N., Kotowska, D., Kristensen, C. M., Olesen, J., Lützhøft, D. O., Halling, J. F., Hansen, M. A., Al‐Soud, W. A., Hansen, L. H., Kiilerich, P., et al. (2018) · Physiological Reports · doi:10.14814/phy2.13881 · Cited by 34
Manipulation of the Gut Microbiome Alters Acetaminophen Biodisposition in Mice
Malfatti, M. A., Kuhn, E. A., Murugesh, D. K., Mendez, M. E., Hum, N. R., Thissen, J. B., Jaing, C. J., & Loots, G. G. (2020) · Scientific Reports · doi:10.1038/s41598-020-60982-8 · Cited by 35
Barretto, S. A., Lasserre, F., Huillet, M., Régnier, M., Polizzi, A., Lippi, Y., Fougerat, A., Person, E., Bruel, S., Bétoulières, C., et al. (2021) · Microbiome · doi:10.1186/s40168-021-01050-9 · Cited by 42
“In recent years, the gut microbial metabolism has been shown to influence the efficacy and toxicity of orally administered drugs [67, 68] and food pollutants [69].”
BackgroundPolyphenolic Nutraceuticals to Combat Oxidative Stress Through Microbiota Modulation
Vamanu, E. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00492 · Cited by 34
“For instance, doxorubicin, which induces cardiac damage, azidothymidine, which induces myopathy, or cisplatin, which induces ototoxicity, possess well-established mechanisms (Carmody and Turnbaugh, 2014).”
BackgroundChaplin, A. M. L., Gao, H., Asase, C., Palanivel, R., Park, B., Skander, D., Bebek, G., Rajagopalan, S., & Maiseyeu, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-69745-x · Cited by 34
Potential Implications of Gut Microbiota in Drug Pharmacokinetics and Bioavailability
Flowers, S. A., Bhat, S., & Lee, J. C. (2020) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2428 · Cited by 35
“Recent data also suggest that short chain fatty acids (SCFAs), which are microbial-derived products of resistant starch (RS) metabolism, stabilize the AHR, thereby increasing activity in the presence of true AHR ligands.(67) Gut microbiota also contribute to regulation of CYP3A11 in mice, analogous to CYP3A4 in humans.”
BackgroundNext Generation Probiotics for Neutralizing Obesogenic Effects: Taxa Culturing Searching Strategies
López‐Moreno, A., Acuña, I., Torres-Sánchez, A., Ruiz-Moreno, Á., Cerk, K., Rivas, A., Suárez, A., Monteoliva‐Sánchez, M., & Aguilera, J. (2021) · Nutrients · doi:10.3390/nu13051617 · Cited by 35
Peng, Y., Tao, H., Wang, S., Xiao, J., Wang, Y., & Su, H. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104463 · Cited by 31
Feng, W., Liu, J., Huang, L., Tan, Y., & Peng, C. Y. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111047 · Cited by 34
Is Extra Virgin Olive Oil an Ally for Women’s and Men’s Cardiovascular Health?
Franconi, F., Campesi, I., & Romani, A. (2020) · Cardiovascular Therapeutics · doi:10.1155/2020/6719301 · Cited by 31
“Considering the role of gut microbiota in sex healthcare paradigm [122, 123] and their ability to expand metabolic activity of the host [124], it important to recall that they could be a modifier of the activity and kinetic of all compounds present in olive and leaves and other matrixes [125].”
BackgroundDong, J., Gao, H.-L., Wang, W., Yu, X., & Liu, L. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188484 · Cited by 30
The Opportunities of Metabolomics in Drug Safety Evaluation
Wang, P., Shehu, A. I., & Ma, X. (2017) · Current Pharmacology Reports · doi:10.1007/s40495-016-0079-5 · Cited by 29
Cheng, Z., Sun, H., Sidhu, H. S., Sy, N. D., & Gan, J. J. (2020) · Environmental Pollution · doi:10.1016/j.envpol.2020.114886 · Cited by 29
Gut microbial dysbiosis and its association with esophageal cancer
Ishaq, H. M., Mohammad, I. S., Muhammad, K. S., Li, H., Abbas, R. Z., Sindhu, Z. U. D., Ullah, S., Yang, F., Sadiq, A., Raza, M. A., et al. (2021) · Journal of Applied Biomedicine · doi:10.32725/jab.2021.005 · Cited by 29
“Consequently, the microbiota has the potential capacity to alter the efficacy and toxicity of chemotherapy (Carmody and Turnbaugh, 2014).”
BackgroundThe Role of Polyphenols in Regulation of Heat Shock Proteins and Gut Microbiota in Weaning Stress
Hussain, T., Wang, J., Murtaza, G., Metwally, E., Yang, H., Kalhoro, M. S., Kalhoro, D. H., Rahu, B. A., Tan, B., Sahito, R. G. A., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6676444 · Cited by 32
“In the pig industry, the gastrointestinal tract of neonatal piglets is prone to postweaning diarrhea [78, 79] and other intestinal disorders which may directly influence intestinal absorption, intestinal barrier injury, inflammation, oxidative damage, and altered microbial response [62, 78].”
BackgroundNeuro-Nutraceutical Polyphenols: How Far Are We?
Gentile, M. T., Camerino, I., Ciarmiello, L. F., Woodrow, P., Muscariello, L., Chiara, I. D., & Pacifico, S. (2023) · Antioxidants · doi:10.3390/antiox12030539 · Cited by 27
“In addition, the biological activity of the derivative metabolites may differ upon their fermentation by gut microbiota [28].”
BackgroundAn integrated host-microbiome response to atrazine exposure mediates toxicity in Drosophila
Brown, J. B., Langley, S. A., Snijders, A. M., Wan, K. H., Morris, S. N. S., Booth, B. W., Fisher, W. W., Hammonds, A. S., Park, S., Weiszmann, R., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02847-y · Cited by 27
Beta-Glucuronidase Inhibition by Constituents of Mulberry Bark
Bai, Y., Chen, L., Cao, Y., Hou, X.-D., Jia, S.-N., Zhou, Q., He, Y., & Hou, J. (2021) · Planta Medica · doi:10.1055/a-1402-6431 · Cited by 26
“Therefore, it is urgent and necessary to find more efficacious EcGUS inhibitors possessing good safety profiles for the prevention and treatment of irinotecan-induced intestinal toxicity and other β-GUS-associated intestinal dysfunction [29,30].”
BackgroundThe microbiota revolution: Excitement and caution
Rescigno, M. (2017) · European Journal of Immunology · doi:10.1002/eji.201646576 · Cited by 27
The role of the gut microbiome in gastrointestinal cancers
Mishra, Y., Ranjan, A., Mishra, V. K., Chattaraj, A., Aljabali, A. A. A., El‐Tanani, M., Hromić‐Jahjefendić, A., Uversky, V. N., & Tambuwala, M. M. (2023) · Cellular Signalling · doi:10.1016/j.cellsig.2023.111013 · Cited by 28
A Metagenomic Insight Into the Human Microbiome
Saxena, R., & Sharma, V. K. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-420196-5.00009-5 · Cited by 28
Liu, H., Tan, K., Zhang, X., Zhang, H., Cheng, D., Ting, Y., Li, S., Ma, H., & Zheng, H. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00036 · Cited by 24
“, 2015), as well as some digestive enzymes (Yolton and Savage, 1976; Dabek et al., 2008; Carmody and Turnbaugh, 2014) that are beneficial to the host.”
BackgroundBasic Definitions and Concepts: Organization of the Gut Microbiome
Quigley, E. M. M. (2017) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2016.09.002 · Cited by 23
Li, N., Wang, B., Wu, Y., Luo, X., Chen, Z., Sang, C., & Xiong, T. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109044 · Cited by 23
Guan, G., Wang, H., Chen, S., Liu, G., Xiong, X., Tan, B., Duraipandiyan, V., Al-Dhabi, N. A., & Fang, J. Q. (2016) · Mediators of Inflammation · doi:10.1155/2016/9236196 · Cited by 23
“Significant changes in the natural microbiota homeostasis have been linked to various illnesses in humans [12].”
BackgroundOmics for Understanding the Gut‐Liver‐Microbiome Axis and Precision Medicine
Khalsa, J. H., Duffy, L. C., Riscuta, G., Starke-Reed, P. E., & Hubbard, V. S. (2017) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.310 · Cited by 22
Jiao, J., Zhang, X., Wang, M., Zhou, C., Yan, Q., & Tan, Z. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b05591 · Cited by 22
Virome Sequencing of the Human Intestinal Mucosal–Luminal Interface
Yan, A., Butcher, J., Mack, D. R., & Stintzi, A. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.582187 · Cited by 22
“These microbes mostly reside in the gastrointestinal tract and are implicated in human health and disease, ranging from immune system development (Belkaid and Timothy, 2014) to nutrient and drug metabolism (Carmody and Turnbaugh, 2014) to involvement in conditions including obesity, inflammatory bowel disease, and can…”
BackgroundGogokhia, L., Tran, N., Grier, A., Nagayama, M., Xiang, G., Funez-dePagnier, G., Lavergne, A., Ericsson, C., Maamar, S. B., Zhang, M., et al. (2025) · Med · doi:10.1016/j.medj.2025.100707 · Cited by 22
Vuong, H. E., Coley, E. J. L., Kazantsev, M., Cooke, M. E., Rendon, T. K., Paramo, J., & Hsiao, E. Y. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113353 · Cited by 19
Zhang, L., Wang, P., Shi, M., Fang, Z., Ji, J., Liao, X., Hu, X., & Chen, F. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108365 · Cited by 20
Gronich, N., Geva‐Zatorsky, N., Herren, R., Kelly, L., Cohen, Z., Zhou, H., Chen, Y. H., Shah, K., Robinson‐Catala, T. A., Frisby, G., et al. (2025) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.70066 · Cited by 25
Dietary Fibers: A Way to a Healthy Microbiome
Sharma, P., Bhandari, C., Kumar, S., Sharma, B., Bhadwal, P., & Agnihotri, N. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811440-7.00011-9 · Cited by 19
Regulation of CYP450 and drug transporter mediated by gut microbiota under high-altitude hypoxia
Bai, X., Yang, J., Liu, G., Zhu, J., Wang, Q., Gu, W., La, L., & Li, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.977370 · Cited by 18
“The gut microbiota may directly utilize distinct microbial enzymes and metabolites to participate in drug metabolism and may also indirectly modify the biotransformation of drugs by regulating CYP450 and drug transporter (Carmody and Turnbaugh, 2014; Li et al., 2016).”
BackgroundMalwe, A. S., & Sharma, V. K. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1254073 · Cited by 22
“Azoreduction performed by gut bacterial azoreductase cleaves the diazo coupling to release 5-ASA that has anti-inflammatory activity, thus reducing pro-inflammatory conditions associated with ulcerative colitis (Carmody and Turnbaugh, 2014; Crouwel et al., 2021).”
Reese, A. T., & Carmody, R. N. (2018) · Applied and Environmental Microbiology · doi:10.1128/aem.02246-18 · Cited by 19
“Numerous therapeutic and diet-derived xenobiotics are known to change gut microbial growth in vivo (167) and in vitro (168).”
BackgroundSelf-citationGargis, A. S., McLaughlin, H. P., Conley, A. B., Lascols, C., Michel, P. A., Gee, J. E., Marston, C. K., Kolton, C. B., Rodriguez‐R, L. M., Hoffmaster, A. R., et al. (2018) · mSystems · doi:10.1128/msystems.00154-18 · Cited by 20
Lu, Z., Shi, M., Tian, M., Wang, X., Ji, J., Liao, X., Hu, X., & Chen, F. (2020) · Food Frontiers · doi:10.1002/fft2.31 · Cited by 18
Sources of Interindividual Variability
Lin, Y. S., Thummel, K. E., Thompson, B. D., Totah, R. A., & Cho, C. W. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1554-6_17 · Cited by 18
The Urogenital System Microbiota: Is It a New Gamechanger in Urogenital Cancers?
Ece, G. T., Aktaş, A., Caner, A., Sağlık, İ., Atik, T. K., Bağcı, Ö. U., Bilman, F. B., Demirbakan, H., Havuz, S. G., Kaya, E., et al. (2025) · Microorganisms · doi:10.3390/microorganisms13020315 · Cited by 16
“…of thyroid hormones and cortisol, which may alter cellular function, metabolism, and stress responses, thereby contributing to cancer development [59]. genotoxic metabolites are often overproduced in dysbiosis, Some gut microbes also produce genotoxic metabolites that can damage DNA, leading to…”
Gut microbiota severely hampers the efficacy of NAD-lowering therapy in leukemia
ElMokh, O., Matsumoto, S., Biniecka, P., Bellotti, A., Schaeuble, K., Piacente, F., Gallart‐Ayala, H., Ivanišević, J., Stamenkovic, I., Nencioni, A., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04763-3 · Cited by 16
Mahran, E., Keusgen, M., & Morlock, G. E. (2020) · Analytica Chimica Acta X · doi:10.1016/j.acax.2020.100039 · Cited by 16
“irinotecan-induced severe diarrhea and NSAID-associated serious intestinal injury [4,5].”
BackgroundGiménez‐Bastida, J. A., Carreras, L. M., Moya-Pérez, Á., & Llopis, J. M. L. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.10.031 · Cited by 19
Ge, Y., Ma, Y., Zhao, M., Wei, J., Wu, X., Zhang, Z., Yang, H. Y., Lei, H., & Wu, B. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114699 · Cited by 15
Microbiota and cancer: an update
Vallianou, N. G., & Tzortzatou-Stathopoulou, F. F. (2019) · Journal of Chemotherapy · doi:10.1080/1120009x.2018.1541046 · Cited by 15
Tumor Profiling at the Service of Cancer Therapy
Fernández–Rozadilla, C., Simões, A. R., LLeonart, M. E., Carnero, A., & Carracedo, Á. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.595613 · Cited by 17
Gut Microbiota as the Potential Mechanism to Mediate Drug Metabolism Under High-altitude Hypoxia
Bai, X., Liu, G., Yang, J., Zhu, J., & Li, X. (2022) · Current Drug Metabolism · doi:10.2174/1389200223666220128141038 · Cited by 15
Xin, X., Huang, G., Zhou, X., Sun, W., Jin, C., Jiang, W., & Zhao, S. L. (2016) · Journal of Adhesion Science and Technology · doi:10.1080/01694243.2016.1242219 · Cited by 15
Mortelé, O., Iturrospe, E., Breynaert, A., Verdickt, E., Xavier, B. B., Lammens, C., Malhotra‐Kumar, S., Jorens, P. G., Pieters, L. A. C., van Nuijs, A. L. N., et al. (2019) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2019.07.016 · Cited by 15
Chauveau, A., Treyer, A., Geirnaert, A., Bircher, L., Babst, A., Abegg, V. F., Simões‐Wüst, A. P., Lacroix, C., Potterat, O., & Hamburger, M. O. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114652 · Cited by 14
Potential of Postbiotics for the Biodegradation of Xenobiotics: A Review
Khani, N., Soleimani, R. A., & Rad, A. H. (2025) · Current Nutrition & Food Science · doi:10.2174/0115734013325225241211033631 · Cited by 15
Mutualism breakdown underpins evolutionary rescue in an obligate cross-feeding bacterial consortium
Melero‐Jiménez, I. J., Sorokin, Y., Merlin, A., Li, J., Couce, A., & Friedman, J. (2025) · Nature Communications · doi:10.1038/s41467-025-58742-1 · Cited by 13
“In medicine, insights into the thresholds at which host-microbe mutualisms 53,54 break — whether due to antibiotics 55 , dietary changes 56 , or infections 57 — could guide preventive therapies using targeted prebiotics or probiotics to maintain a balanced microbiome 58,59 .”
Therapeutic implications of the gastrointestinal microbiome
Kashyap, P., & Quigley, E. M. M. (2018) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2018.01.004 · Cited by 15
Cuevas-González, P. F., Peredo-Lovillo, A. G., Castro-López, C., Vallejo‐Córdoba, B., González-Córdova, A. F., Garcia, H. S., & Hernández‐Mendoza, A. (2021) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2021.09.004 · Cited by 14
An updated review on advantages, disadvantages and uncertainties associated with probiotics
Pandey, K., Gosai, H. B., & Patel, R. B. (2025) · Journal of Dairy Research · doi:10.1017/s0022029925101155 · Cited by 17
“Specifically, when these rats were treated with antibiotics, the urinary excretion of total sulphanilamide was significantly reduced, indicating that drug activation is microbiota-dependent (Gingell and Bridges, 1971; Carmody and Turnbaugh, 2014).”
Tannock, G. W. (2023) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00127-22 · Cited by 15
“Pharmaceuticals may be inactivated (for example, digoxin inactivated by Eggerthella lenta ) or bioaccumulated by bacteria (for example, the antidepressant duloxetine) (228–231).”
BackgroundNutrition and Microbiome Interactions in Human Cancer
Daschner, P. J., Ross, S., Seifried, H. E., Kumar, A., & Flores, R. (2022) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2022.10.004 · Cited by 15
Immunomodulatory interplay of the microbiome and therapy of rheumatic diseases
Ostrov, B. E., & Amsterdam, D. (2017) · Immunological Investigations · doi:10.1080/08820139.2017.1373828 · Cited by 15
Editorial on "Cancer and the microbiota" published in Science.
Hamm, A. K., & Weir, T. L. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2305-5839.2015.07.16 · Cited by 14
“The gut microbiota is known to directly metabolize dietary compounds and xenobiotics, including cancer drugs, through a variety of mechanisms that humans lack (48).”
BackgroundSynergism of Diet, Genetics, and Microbiome on Health
Das, P., Banka, R., Ghosh, J., Singh, K., Choudhury, S. R., & Koner, S. (2024) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/979-8-3693-5528-2.ch006 · Cited by 11
Hu, Y., Chen, H., Li, P., Li, B., Cao, L., Zhao, C., Gu, Q., & Yin, Y. (2019) · Journal of Visualized Experiments · doi:10.3791/59725 · Cited by 11
Endocrine Disruption and the Gut Microbiome
Acharya, K. D., Parakoyi, A. E. R., & Tetel, M. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821985-0.00015-3 · Cited by 11
“These enzymes modify the actions or route of transport of hormones and hormonelike EDCs by conjugating them to form polar products to be excreted via bile or urine [91].”
BackgroundMehmood, K., Moin, A., Hussain, T., Rizvi, S. M. D., Gowda, D., Shakil, S., & Kamal, M. (2021) · Folia Microbiologica · doi:10.1007/s12223-021-00926-5 · Cited by 11
“It has been established that the metabolism of natural compounds and several food components is affected by microbiome; hence, microbiome interaction with drugs may affect the disease response (Carmody and Turnbaugh 2014).”
BackgroundBaliou, S., Adamaki, M., Spandidos, D. A., Kyriakopoulos, A. M., Christodoulou, I., & Zoumpourlis, V. C. (2018) · World Academy of Sciences Journal · doi:10.3892/wasj.2018.6 · Cited by 11
Kumar, K., Dhoke, G. V., Sharma, A. K., Jaiswal, S. K., & Sharma, V. K. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28396 · Cited by 10
“In addition to the impact of gut microbial diversity or dysbiosis in various human diseases, there is an increasing amount of evidence which shows that the gut microbes can affect the bioavailability and efficacy of various orally administrated drug molecules through promiscuous enzymatic metabolism.(13,14)”
BackgroundThe microbiome: A heritable contributor to bone morphology?
Hernandez, C. J., & Moeller, A. H. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.06.022 · Cited by 9
Nature and nurture: Environmental toxins and biliary atresia
Walesky, C. M., & Goessling, W. (2016) · Hepatology · doi:10.1002/hep.28701 · Cited by 9
“Importantly, it is well established that the gut microbiome can directly biotransform molecules.((7)) Therefore, the microbiome, which can be highly variable between individuals, can directly modulate xenobiotic-induced toxicity.”
BackgroundMetabolic protection by the dietary flavonoid 7,8-dihydroxyflavone requires an intact gut microbiome
Sharma, P., Silva, C. S., Pfreundschuh, S., Ye, H., & Sampath, H. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.987956 · Cited by 8
The Gut Microbiome in Colorectal Cancer
Piawah, S., Walker, E. J., Blarigan, E. L. V., & Atreya, C. E. (2022) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2022.03.001 · Cited by 8
Cellular Stress Responses and Monitored Cellular Activities
Sawa, T., Naito, Y., Kato, H., & Amaya, F. (2016) · Shock · doi:10.1097/shk.0000000000000603 · Cited by 8
Bess, E. N., Bisanz, J. E., Spanogiannopoulos, P., Ang, Q. Y., Bustion, A. E., Kitamura, S., Alba, D., Wolan, D. W., Koliwad, S. K., & Turnbaugh, P. J. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/357640 · Cited by 8
“reach distant tissues following their absorption into general circulation (1-3).”
BackgroundSelf-citationCurrent Aspects of Selected Factors to Modulate Brain Health and Sports Performance in Athletes
Przewłócka, K., Korewo-Labelle, D., Berezka, P., Karnia, M. J., & Kaczor, J. J. (2024) · Nutrients · doi:10.3390/nu16121842 · Cited by 9
“Through metabolic interactions with the intestinal microbiota, polyphenols, as bioactive phenolic metabolites, exhibit many health-related properties, including anti-inflammatory and antioxidant effects [144,145].”
BackgroundAlteration of oral microbiome composition in children living with pesticide-exposed farm workers
Stanaway, I. B., Wallace, J. C., Hong, S., Wilder, C. S., Green, F. H., Tsai, J. M., Knight, M., Workman, T. W., Vigoren, E. M., Smith, M. N., et al. (2022) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2022.114090 · Cited by 6
Transformative Forces: The Role of Gut Microbiota in Processing Environmental Pollutants
Lv, M., Liu, Y., Wang, M., Song, X., Hu, Y., Gao, J., Chen, L., Liu, A., Liu, J., Liu, R., et al. (2025) · Environmental Science & Technology · doi:10.1021/acs.est.5c01928 · Cited by 8
Treatment of Hyperammonemia by Transplanting a Symbiotic Pair of Intestinal Microbes
Liu, J., Zhai, C., Rho, J., Lee, S.-B., Heo, H. J., Kim, S. W., Kim, H., & Hong, S. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.696044 · Cited by 6
“The human gut microbiota is a massive and complex microbial community consisting of 100 trillion microbes in the intestine, contributing significantly to human traits as much as our genes, especially in the case of atherosclerosis, hypertension, obesity, diabetes, metabolic syndrome, inflammatory bowel disease, GI tra…”
BackgroundSilini, A. R., Ramuta, T. Ž., Pires, A. S., Banerjee, A., Dubus, M., Gindraux, F., Kerdjoudj, H., Mačiulaitis, J., Weidinger, A., Wolbank, S., et al. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.958669 · Cited by 6
“pharmacokinetics, antitumor activity and drug toxicity of chemotherapeutic agents by 1) changing the chemical structure of the drug (biotransformation) (Haiser and Turnbaugh 2012; Wilson and Nicholson 2017), 2) decreasing the absorption of certain drugs (Carmody and Turnbaugh 2014), or even indirectly by 3) affecting…”
BackgroundHuman microbiome studies in Korea
Choi, S.-M., Cho, S., & Yi, H. (2016) · Allergy Asthma & Respiratory Disease · doi:10.4168/aard.2016.4.5.311 · Cited by 6
“체내에 유입된 약물이나 발암 물질로부터 인간을 보호하는 기능 이 있다.(23,24) 장내 마이크로바이옴에 의한 탈수산화, 탈카르복실화,”
Benefits of Probiotics—Biodetoxification
Sionek, B., Szydłowska, A., Jaworska, D., & Kołożyn‐Krajewska, D. (2025) · Applied Sciences · doi:10.3390/app15105297 · Cited by 10
Abbasi, A., Sheykhsaran, E., Hosseinzadeh, N., Bazdar, M., Hamehjani, M., Aghapour, B., & Shojaee‐Aliabadi, S. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10615-1 · Cited by 7
Zingiberaceae wonders: the antioxidant powerhouse for optimal health
Boyina, H. K., Chakraborty, S., Atrooz, O. M., Adamska, O., Sanka, K., Atanasov, A. G., Stolarczyk, A., Chellammal, H. S. J., Arora, V., Gangarapu, K., et al. (2025) · Animal Science Papers and Reports · doi:10.2478/aspr-2025-0001 · Cited by 7
Forging the microbiome to help us live long and prosper
Rock, R. R., & Turnbaugh, P. J. (2023) · PLoS Biology · doi:10.1371/journal.pbio.3002087 · Cited by 5
“This area of study will benefit from the already extensive literature focused on the role of the gut microbiome in nutrition [48].”
BackgroundSelf-citationThe Microbiome: Genesis and Functions
Appanna, V. D. (2018) · Springer eBooks · doi:10.1007/978-981-10-7684-8_2 · Cited by 5
Come, J., Pereira, J. B., Pinto, R., Carrilho, C., Pereira, L., & Santos, L. L. (2020) · Pathobiology · doi:10.1159/000511422 · Cited by 5
Zheng, S., Wang, L., Xiong, J., Liang, G., Xu, Y., & Fu, L. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c00948 · Cited by 5
Diot, C., García-González, A. P., & Walhout, A. J. M. (2018) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2019.08.001 · Cited by 5
CHEMINFORMATICS TOOLS FOR ENABLING METABOLOMICS
Djoumbou-Feunang, Y. (2017) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3vd6pj8b · Cited by 5
Impact of Polyphenol-Rich Chocolate on Microbial Diversity and Human Health: A Comprehensive Review
Chatterjee, A., Chatterjee, P., Irani, R., Ghosh, S., Basu, B., & Prajapati, B. G. (2025) · Current Nutrition & Food Science · doi:10.2174/0115734013332631250130115501 · Cited by 5
Modulating drug response through the gut microbiome: pathways to precision therapy
Kumar, N., Das, J., Vanangamudi, M., Mojgani, N., Islam, A., Sridhar, S. B., Sharma, H., Kumar, S., Panigrahy, U. P., Mantry, S., et al. (2026) · Archives of Microbiology · doi:10.1007/s00203-025-04688-3 · Cited by 4
“Various categories of pharmaceuticals and dietary supplements have been documented to modify the gut microbial makeup in ways that are considered harmful to wellbeing (Carmody and Turnbaugh et al. 2014).”
Exploring Gut Microbiome Variations between Popillia japonica Populations of Azores
Frías, J., Garriga, A., Peñalver, Á., Teixeira, M. B., Beltrí, R., Toubarro, D., & Simões, N. (2023) · Microorganisms · doi:10.3390/microorganisms11081972 · Cited by 4
“Additionally, relevant genes and proteins were enriched in larvae from the HD site, such as genes coding for cytochrome P450 and for mitochondrial biogenesis, cytokine receptor, and membrane trafficking proteins.”
BackgroundRecent Progress on Strategies and Applications of Imaging for Intestinal Microflora
Li, N., Tan, X., & Yang, Q. (2022) · Chinese Journal of Organic Chemistry · doi:10.6023/cjoc202112022 · Cited by 4
Ahmed, L. A., & Al‐Massri, K. F. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178210 · Cited by 3
Wu, S., Sui, Z., Pan, J., Men, X., Li, X., Xue, D., Meng, Q., Han, X., & Shen, Y. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1750434 · Cited by 3
“They also suppress protein tyrosine phosphatase 1B (PTP1B) activity, thereby enhancing insulin signaling and sensitivity (73).”
Chandra, Q. M., Clister, D., Halim, P., Dalimunthe, A., Ichwan, M., Sari, D. K., Umaya, C., Aktary, N., Rani, A., Park, M. N., et al. (2026) · Clinica Chimica Acta · doi:10.1016/j.cca.2026.120941 · Cited by 3
McDonald, J. E., Harris, R. N., Doonan, J., Carryl, S. S., Sze, M. A., McKenzie, V. J., & Gilbert, J. A. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108654418.007 · Cited by 3
Developmental Immunotoxicology Testing (DIT)
Holsapple, M. P., Prell, R. A., & Comstock, S. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65734-3 · Cited by 3
Chlorogenic Acid as a Model Compound for Optimization of an In Vitro Gut Microbiome-Metabolism Model
Mortelé, O., Iturrospe, E., Breynaert, A., Lammens, C., Xavier, B. B., Malhotra‐Kumar, S., Jorens, P. G., Pieters, L. A. C., van Nuijs, A. L. N., & Hermans, N. (2019) · COST Action CA16112 NutRedOx Meeting · doi:10.3390/proceedings2019011031 · Cited by 3
“Conversion of a prodrug to the active compound, inactivation, detoxification, change of efficacy and direct binding to xenobiotics or dietary molecules are examples of direct interferences [11,21].”
Background
Metadata
- Authors
- Carmody, R. N., & Turnbaugh, P. J.
- Corresponding author
- Turnbaugh, Peter J.
- Venue
- Journal of Clinical Investigation
- Published
- 2014-08-08
- Volume
- 124
- Issue
- 10
- Pages
- 4173-4181
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC4191041
- OpenAlex
- W1964115194
- Cited by
- 268
- References
- 91
- Citations by year
- 2026: 17 · 2025: 16 · 2024: 10 · 2023: 15 · 2022: 23 · 2021: 47 · 2020: 33 · 2019: 26 · 2018: 21 · 2017: 19 · 2016: 23 · 2015: 14 · 2014: 3
- FWCI
- 1.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Harvard University
- National Institutes of Health
- FAS Center for Systems Biology, Harvard University
- National Institute of General Medical Sciences (P50GM068763)
- National Institute of Diabetes and Digestive and Kidney Diseases (F32DK101154)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- host-microbe interactions, gut microbiota, xenobiotic metabolism, drug metabolism, therapeutic drugs, personalized medicine
- MeSH terms
- Animals, Binding Sites, Diet, Humans, Intestines, Mice, Transgenic, Protein Binding, Xenobiotics, Gene Expression Regulation, Bacterial, Probiotics, Gastrointestinal Tract, Mice, Microbial Interactions, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review